Increase of Apoptosis in a Murine Model for Severe Pneumococcal Pneumonia during Influenza A Virus Infection

被引:1
|
作者
Kosai, Kosuke [2 ]
Seki, Masafumi [1 ,2 ]
Tanaka, Akitaka [2 ]
Morinaga, Yoshitomo [2 ]
Imamura, Yoshifumi [2 ]
Izumikawa, Koichi [2 ]
Kakeya, Hiroshi [2 ]
Yamamoto, Yoshihiro [2 ]
Yanagihara, Katsunori [2 ]
Tomono, Kazunori [1 ]
Kohno, Shigeru [2 ]
机构
[1] Osaka Univ Hosp, Div Infectious Dis & Prevent, Suita, Osaka 5650871, Japan
[2] Nagasaki Univ, Dept Internal Med 2, Nagasaki 8528501, Japan
基金
日本学术振兴会;
关键词
BACTERIAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; DEATH; EXPRESSION; CLEARANCE; INDUCTION; CELLS; MICE; PREPAREDNESS; INFLAMMATION;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The mechanisms of severe pneumonia caused by co-infection of bacteria and influenza A virus (IAV) have not been fully elucidated. We examined apoptosis and inflammatory responses in a murine model for pneumococcal pneumonia during IAV infection. Inflammation, respiratory epithelium apoptosis, and inflammatory-cell infiltration increased in a time dependent manner in the lungs of mice co-infected with Streptococcus pneumoniae and IAV, in comparison with those infected with either S. pneumoniae or IAV. According to appearance of terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cells, caspase-3 and -8 were activated 24 h after S. pneumoniae infection, and caspase-3 activation decreased after 48 h, whereas inflammatory cytokine levels continued to increase in co-infected mice. In contrast, in mice infected with either IAV or S. pneumoniae, apoptosis and activation of factors related to caspase-3 peaked at 48 h. Furthermore, Fas-associated death domain was significantly expressed in the lungs of co-infected mice 24 h after S. pneumoniae infection. These data suggest that early onset of apoptosis and its related factors play important roles in fulminant pneumonia resulting from bacterial pneumonia complicated by co-infection with influenza virus.
引用
收藏
页码:451 / 457
页数:7
相关论文
共 50 条
  • [1] A mathematical model of intrahost pneumococcal pneumonia infection dynamics in murine strains
    Mochan, Ericka
    Swigon, David
    Ermentrout, G. Bard
    Lukens, Sarah
    Clermont, Gilles
    JOURNAL OF THEORETICAL BIOLOGY, 2014, 353 : 44 - 54
  • [2] Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model
    Isono, Toshihito
    Domon, Hisanori
    Nagai, Kosuke
    Maekawa, Tomoki
    Tamura, Hikaru
    Hiyoshi, Takumi
    Yanagihara, Katsunori
    Kunitomo, Eiji
    Takenaka, Shoji
    Noiri, Yuichiro
    Terao, Yutaka
    PLOS ONE, 2020, 15 (10):
  • [3] Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection
    Fukuda, Yoshiko
    Furuya, Yuri
    Nozaki, Yusuke
    Takahata, Masahiro
    Nomura, Nobuhiko
    Mitsuyama, Junichi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 78 (02) : 168 - 171
  • [4] Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
    Melo, Eliza M.
    Del Sarto, Juliana
    Vago, Juliana P.
    Tavares, Luciana P.
    Rago, Flavia
    Goncalves, Ana Paula F.
    Machado, Marina G.
    Aranda-Pardos, Irene
    Valiate, Bruno V. S.
    Cassali, Geovanni D.
    Pinho, Vanessa
    Sousa, Lirlandia P.
    A-Gonzalez, Noelia
    Campagnole-Santos, Maria Jose
    Bader, Michael
    Santos, Robson A. S.
    Machado, Alexandre, V
    Ludwig, Stephan
    Teixeira, Mauro M.
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [5] Outbreaks of influenza B infection and pneumococcal pneumonia at a mental health facility in Japan
    Yamazaki, Yoshitaka
    Goto, Norihiko
    Iwanami, Naoya
    Hama, Mineyuki
    Fujiwara, Noriko
    Takahashi, Yuko
    Sekiguchi, Maki
    Chang, Bin
    Yamazaki, Munehiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (12) : 837 - 840
  • [6] CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
    Tavares, Luciana P.
    Garcia, Cristiana C.
    Machado, Marina G.
    Queiroz-Junior, Celso M.
    Barthelemy, Adeline
    Trottein, Francois
    Siqueira, Marilda M.
    Brandolini, Laura
    Allegretti, Marcello
    Machado, Alexandre M.
    de Sousa, Lirlandia P.
    Teixeira, Mauro M.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [7] Impact of Influenza on Pneumococcal Vaccine Effectiveness during Streptococcus pneumoniae Infection in Aged Murine Lung
    Jirru, Ermias
    Lee, Stefi
    Harris, Rebecca
    Yang, Jianjun
    Cho, Soo Jung
    Stout-Delgado, Heather
    VACCINES, 2020, 8 (02) : 1 - 15
  • [8] Effect of Influenza Virus Infection in a Murine Model of Asthma
    Kim, Hwan Soo
    Lee, Huisu
    Kim, Hyun Sook
    Won, Sulmui
    Lee, Eu Kyoung
    Bang, Kyongwon
    Chun, Yoon Hong
    Yoon, Jong-seo
    Kim, Hyun Hee
    Kim, Jin Tack
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (04) : 392 - 401
  • [9] Post-immunobiotics increase resistance to primary respiratory syncytial virus infection and secondary pneumococcal pneumonia
    Tonetti, F. Raya
    Tomokiyo, M.
    Fukuyama, K.
    Elean, M.
    Moyano, R. Ortiz
    Yamamuro, H.
    Shibata, R.
    Quilodran-Vega, S.
    Kurata, S.
    Villena, J.
    Kitazawa, H.
    BENEFICIAL MICROBES, 2023, 14 (03) : 209 - 221
  • [10] Effective prevention of secondary pneumococcal infection following influenza virus infection
    Seon, Seung Han
    Rhee, Dong-Kwon
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 953 - 955